Humira (adalimumab) is an injectable prescription medication used to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. It works by targeting and blocking tumor necrosis factor (TNF), a protein that contributes to inflammation in the body.
Who Should Consider Humira? Humira is suitable for adults and in some cases children who:
- Have moderate to severe rheumatoid arthritis.
- Suffer from psoriatic arthritis.
- Are diagnosed with ankylosing spondylitis.
- Require treatment for Crohn’s disease or ulcerative colitis.
- Have moderate to severe plaque psoriasis.
- Children with juvenile idiopathic arthritis.
How is Humira Administered? Humira is administered through subcutaneous injection. Common sites for injection include the thigh or lower abdomen. Patients are typically instructed by healthcare professionals on how to self-administer using a pre-filled syringe or auto-injector. The dosing frequency depends on the condition being treated but generally involves injections every other week after initial loading doses.
Important Information for Humira Users:
- How to Use: Follow your healthcare provider’s instructions for self-administering Humira injections.
- Storage: Store Humira in the refrigerator. Allow the medication to reach room temperature before injecting to minimize discomfort.
- Side Effects: Common side effects include injection site reactions, upper respiratory infections, headache, and rash. Report any severe or unexpected symptoms to your healthcare provider.
- Monitoring: Regular medical check-ups and possibly blood tests are recommended to monitor the effectiveness of the treatment and to manage any side effects.
Medication Warnings
- Infections: Humira can compromise the immune system, increasing the risk of serious infections. Promptly report any signs of infection, such as fever, chills, or persistent cough, to your healthcare provider.
- Allergic Reactions: Seek immediate medical help if you experience symptoms like rash, hives, swelling of the face, or difficulty breathing.
- Neurological Problems: Rarely, Humira can cause neurological problems, including multiple sclerosis, seizures, and optic neuritis. Discuss any personal or family history of neurological disorders with your doctor.
- Heart Failure: Adalimumab may worsen or cause new onset of heart failure. Notify your healthcare provider if you develop symptoms like shortness of breath or swelling of the ankles.
Who Should and Shouldn’t Take Humira?
- Suitable Candidates:
- Individuals diagnosed with specific inflammatory diseases requiring TNF inhibition.
- Patients who have not responded adequately to standard therapies.
- Unsuitable Candidates:
- Individuals with active, severe infections.
- Patients with known hypersensitivity to adalimumab or any components of the formulation.
- Those with a history of heart failure or significant neurological disorders, unless closely monitored by a healthcare provider.
For more comprehensive information and personalized advice, consult your healthcare provider.
